Huang Mingyue, founder and CEO of Baiyi Pharmaceutical, has over 30 years of experience in medical and innovative drug research and development. Received clinical medical education in the early years, and later went to the United States to study molecular biology. I have worked for over 20 years in internationally renowned biopharmaceutical companies such as Anjin and Takeda. Founded in 2021, Baiyi Pharmaceutical is committed to developing innovative therapies for the nervous system with global competitiveness. We have established technology platforms such as AI protein design, multispecific antibodies, and long-acting protein engineering, promoting multiple innovative projects into preclinical and clinical development.